Obaid Malik, MD
Pain Medicine · Richardson, TXNPI 1972946077
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,743 of the $9,715 with a category attached, or 79.7%. 38 manufacturers reported payments, led by Medtronic at 30.0% of the total. Reporting peaked in 2019 at $2,956 and has fallen 79.5% since, to $607 in 2025.
Across 290 payments — averaging $33.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Biohaven Pharmaceuticals, Inc.$1K
- Abbott$1K
- Nevro Corp.$705
- Boston Scientific$418
- Collegium Pharmaceutical, Inc.$311
- plus $3K from 32 others
What the payments were for
- Consulting fees$1,20012%
- Speaking & faculty fees$200%
- Travel & lodging$7528%
- Food & beverage$7,74380%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS$1,480
- NURTEC ODT$1,200
- Senza Spinal Cord Stimulation System$285
- ReActiv8$161
- PROCLAIM$160
- StimQ Receiver Stimulator Kit Channel A US w Receiver$149
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$149
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$149
- Freedom 4A Receiver Kit Channel A US w Receiver$149
- Freedom 8A Receiver Kit Channel A US w Receiver$149
- Omnia$147
- KYPHON Balloon Kyphoplasty$142
- Octrode SCS Leads$140
- SPECTRA WAVEWRITER$123
- CODMAN CERTAS$120
- CUSA CLARITY$120
- DURAGEN DURAL GRAFT MATRIX$120
- DURASEAL EXACT SPINAL SEALANT SYSTEM$120
- HAKIM$120
- RESTORE$114
How this compares
$9,715 in reported general payments places this provider in the 75th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 331 | $6,313 |
| Gabapentin | 258 | $5,316 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 161 | $4,604 |
| Pregabalin | 139 | $3,765 |
| Buprenorphine Hcl | 37 | $1,773 |
| Duloxetine Hcl | 52 | $807 |
| Cyclobenzaprine Hcl | 37 | $708 |
| Tramadol Hcl | 95 | $534 |
| Amitriptyline Hcl | 26 | $498 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 39 | $406 |
| Methocarbamol | 20 | $385 |
| Hydromorphone Hcl | 24 | $266 |
| Tizanidine Hcl | 25 | $261 |
| Celecoxib | 13 | $235 |
| Nortriptyline Hcl | 16 | $198 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Richardson
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
- Eduardo GarciaWebster$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.